References
- Thies W, Bleiler L. Alzheimer’s Association. 2013 Alzheimer’s disease facts and figures. Alzheimer’s Dement 2013;9:208-45
- Karran E, Merckan M, De Strooper B. The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov 2011;10:698-712
- Carreiras MC, Mendes E, Perry MJ, et al. The multifactorial nature of Alzheimer’s disease for developing potential therapeutics. Curr Topics Med Chem 2013;13:1745-70
- Francis PT, Palmer AM, Snape M, et al. The cholinergic hypothesis of Alzheimer’s disease: a review of progress. J Neurol Neurosurg Psychiatry 1999;66:137-47
- Tan CC, Yu JT, Wang HF, et al. Efficacy and safety of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease: a systematic review and meta-analysis. J Alzheimer’s Dis 2014;41:615-31
- Birks J. Cholinesterase inhibitors for Alzheimer’s disease. Cochrane Database Syst Rev 2006;1:CD005593
- Broadstock M, Ballard C, Corbett A. Latest treatment options for Alzheimer’s disease, Parkinson’s disease dementia and dementia with Lewy bodies. Expert Opin Pharmacother 2014;15:1797-810
- Yan R, Vassar R. Targeting the β secretase BACE1 for Alzheimer’s disease therapy. Lancet Neurol 2014;13:319-29
- Lannfelt L, Relkin NR, Siemers ER. Amyloid β directed immunotherapy for Alzheimer’s disease. J Int Med 2014;275:284-95
- Lambracht-Washington D, Rosenberg RN. Anti-amyloid beta to tau-based immunization: developments in immunotherapy for Alzheimer disease. Immunotargets Ther 2013;2:105-14
- Persson T, Popescu BO, Cedazo-Minguez A. Oxidative stress in Alzhemier’s disease: Why did antioxidant therapy fail? Oxid Med Cell Long 2014;2014:427318
- Zhou W, Hu W. Anti-neuroinflammatory agents for the treatment of Alzheimer’s disease. Future Med Chem 2013;5:1559-71
- Morales I, Guzmán-Martinez L, Cerda-Troncoso C, et al. Neuroinflammation in the pathogenesis of Alzheimer’s disease. A rational framework for the search of novel therapeutic approaches. Front Cell Neurosci 2014;8:112
- Crichton GE, Bryan J, Murphy KJ. Dietary antioxidants, cognitive function and dementia – a systematic review. Plant Foods Hum Nutr 2013;68:279-92
- Darvesh AS, Carroll RT, Geldenhuys WJ, et al. Oxidative stress and Alzheimer’s disease: dietary polyphenols as potential therapeutic agents. Expert Rev Neurother 2010;10:729-45
- Soni M, Rahardjo TB, Soekardi R, et al. Phytoestrogens and cognitive function: a review. Maturitas 2014;77:209-20
- Yang M, Xu DD, Zhang Y, et al. A systematic review on natural medicines for the prevention and treatment of Alzheimer’s disease with meta-analysis of intervention effect of ginkgo. Amer J Chinese Med 2014;42:505-21
- Froestl W, Muhs A, Pfeifer A. Cognitive enhancers (Nootropics). Part 1: drugs interacting with receptors. J Alzheimer’s Dis 2014;41:961-1019
- Froestl W, Muhs A, Pfeifer A. Cognitive enhancers (Nootropics). Part 2: drugs interacting with enzymes. J Alzheimer’s Dis 2013;33:547-658
- Bajda M, Guzior N, Ignasik M. Multi-target-directed ligands in Alzheimer’s treatment. Curr Med Chem 2011;18:4949-75